ID MMP14_RAT Reviewed; 582 AA. AC Q10739; Q6IN06; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2007, sequence version 2. DT 24-JAN-2024, entry version 185. DE RecName: Full=Matrix metalloproteinase-14; DE Short=MMP-14; DE EC=3.4.24.80; DE AltName: Full=Membrane-type matrix metalloproteinase 1; DE Short=MT-MMP 1; DE Short=MTMMP1; DE AltName: Full=Membrane-type-1 matrix metalloproteinase; DE Short=MT-MMP; DE Short=MT1-MMP; DE Short=MT1MMP; DE Flags: Precursor; GN Name=Mmp14; Synonyms=Mtmmp; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=7708715; DOI=10.1073/pnas.92.7.2730; RA Okada A., Bellocq J.-P., Rouyer N., Chenard M.P., Rio M.C., Chambon P., RA Basset P.; RT "Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in RT stromal cells of human colon, breast, and head and neck carcinomas."; RL Proc. Natl. Acad. Sci. U.S.A. 92:2730-2734(1995). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Cossins J., Clements J., Catlin G., Wells G.; RT "Expression and function of MT-MMP in glial cells."; RL Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Heart; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Endopeptidase that degrades various components of the CC extracellular matrix such as collagen. Activates progelatinase A. CC Essential for pericellular collagenolysis and modeling of skeletal and CC extraskeletal connective tissues during development. May be involved in CC actin cytoskeleton reorganization by cleaving PTK7. Acts as a positive CC regulator of cell growth and migration via activation of MMP15 in CC association with pro-MMP2. Involved in the formation of the CC fibrovascular tissues in association with pro-MMP2. Cleaves ADGRB1 to CC release vasculostatin-40 which inhibits angiogenesis. CC {ECO:0000250|UniProtKB:P50281, ECO:0000250|UniProtKB:P53690}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Endopeptidase activity. Activates progelatinase A by cleavage CC of the propeptide at 37-Asn-|-Leu-38. Other bonds hydrolyzed include CC 35-Gly-|-Ile-36 in the propeptide of collagenase 3, and 341-Asn-|- CC Phe-342, 441-Asp-|-Leu-442 and 354-Gln-|-Thr-355 in the aggrecan CC interglobular domain.; EC=3.4.24.80; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250}; CC Note=Binds 1 zinc ion per subunit. {ECO:0000250}; CC -!- COFACTOR: CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250}; CC -!- SUBUNIT: Interacts (via C-terminal cytoplasmic tail) with BST2. CC Interacts with DLL1; inhibits DLL1-induced Notch signaling. CC {ECO:0000250|UniProtKB:P50281}. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I CC membrane protein {ECO:0000305}. Melanosome {ECO:0000250}. Cytoplasm CC {ECO:0000250}. Note=Forms a complex with BST2 and localizes to the CC cytoplasm. {ECO:0000250}. CC -!- DOMAIN: The conserved cysteine present in the cysteine-switch motif CC binds the catalytic zinc ion, thus inhibiting the enzyme. The CC dissociation of the cysteine from the zinc ion upon the activation- CC peptide release activates the enzyme. CC -!- PTM: Tyrosine phosphorylated by PKDCC/VLK. CC {ECO:0000250|UniProtKB:P50281}. CC -!- SIMILARITY: Belongs to the peptidase M10A family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X83537; CAA58521.1; -; mRNA. DR EMBL; X91785; CAA62897.1; -; mRNA. DR EMBL; BC072509; AAH72509.1; -; mRNA. DR PIR; I84471; I84471. DR RefSeq; NP_112318.1; NM_031056.1. DR AlphaFoldDB; Q10739; -. DR BMRB; Q10739; -. DR SMR; Q10739; -. DR STRING; 10116.ENSRNOP00000065434; -. DR MEROPS; M10.014; -. DR iPTMnet; Q10739; -. DR PhosphoSitePlus; Q10739; -. DR PaxDb; 10116-ENSRNOP00000065434; -. DR Ensembl; ENSRNOT00000075610.3; ENSRNOP00000065434.1; ENSRNOG00000010947.9. DR Ensembl; ENSRNOT00055020294; ENSRNOP00055016353; ENSRNOG00055011907. DR Ensembl; ENSRNOT00060047919; ENSRNOP00060039863; ENSRNOG00060027477. DR Ensembl; ENSRNOT00065054795; ENSRNOP00065045061; ENSRNOG00065031768. DR GeneID; 81707; -. DR KEGG; rno:81707; -. DR UCSC; RGD:620198; rat. DR AGR; RGD:620198; -. DR CTD; 4323; -. DR RGD; 620198; Mmp14. DR eggNOG; KOG1565; Eukaryota. DR GeneTree; ENSGT00940000157808; -. DR HOGENOM; CLU_015489_8_1_1; -. DR InParanoid; Q10739; -. DR OMA; DIKVWEG; -. DR OrthoDB; 2225278at2759; -. DR PhylomeDB; Q10739; -. DR TreeFam; TF352396; -. DR BRENDA; 3.4.24.80; 5301. DR Reactome; R-RNO-1442490; Collagen degradation. DR Reactome; R-RNO-1474228; Degradation of the extracellular matrix. DR Reactome; R-RNO-1592389; Activation of Matrix Metalloproteinases. DR PRO; PR:Q10739; -. DR Proteomes; UP000002494; Chromosome 15. DR Bgee; ENSRNOG00000010947; Expressed in ovary and 19 other cell types or tissues. DR GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD. DR GO; GO:0005829; C:cytosol; IEA:Ensembl. DR GO; GO:0031012; C:extracellular matrix; IEA:InterPro. DR GO; GO:0005615; C:extracellular space; ISO:RGD. DR GO; GO:0045111; C:intermediate filament cytoskeleton; IEA:Ensembl. DR GO; GO:0044354; C:macropinosome; ISO:RGD. DR GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell. DR GO; GO:0005634; C:nucleus; ISO:RGD. DR GO; GO:0005886; C:plasma membrane; ISO:RGD. DR GO; GO:0004175; F:endopeptidase activity; ISO:RGD. DR GO; GO:0005178; F:integrin binding; IPI:RGD. DR GO; GO:0070006; F:metalloaminopeptidase activity; ISO:RGD. DR GO; GO:0004222; F:metalloendopeptidase activity; ISS:UniProtKB. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0001525; P:angiogenesis; IEP:RGD. DR GO; GO:0043615; P:astrocyte cell migration; IEP:RGD. DR GO; GO:0060348; P:bone development; ISO:RGD. DR GO; GO:0048754; P:branching morphogenesis of an epithelial tube; ISO:RGD. DR GO; GO:0016477; P:cell migration; ISO:RGD. DR GO; GO:0035988; P:chondrocyte proliferation; ISO:RGD. DR GO; GO:0030574; P:collagen catabolic process; ISO:RGD. DR GO; GO:0097094; P:craniofacial suture morphogenesis; ISO:RGD. DR GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; ISO:RGD. DR GO; GO:0001958; P:endochondral ossification; ISO:RGD. DR GO; GO:0035987; P:endodermal cell differentiation; ISO:RGD. DR GO; GO:0001935; P:endothelial cell proliferation; IEP:RGD. DR GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central. DR GO; GO:0060322; P:head development; ISO:RGD. DR GO; GO:0030324; P:lung development; ISO:RGD. DR GO; GO:0008584; P:male gonad development; IEP:RGD. DR GO; GO:0051895; P:negative regulation of focal adhesion assembly; IDA:RGD. DR GO; GO:0045746; P:negative regulation of Notch signaling pathway; ISS:UniProtKB. DR GO; GO:0001503; P:ossification; IEP:RGD. DR GO; GO:0001541; P:ovarian follicle development; IEP:RGD. DR GO; GO:0045579; P:positive regulation of B cell differentiation; ISS:UniProtKB. DR GO; GO:0030307; P:positive regulation of cell growth; ISO:RGD. DR GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD. DR GO; GO:1905523; P:positive regulation of macrophage migration; ISO:RGD. DR GO; GO:0010831; P:positive regulation of myotube differentiation; ISS:UniProtKB. DR GO; GO:0010954; P:positive regulation of protein processing; IMP:RGD. DR GO; GO:0006508; P:proteolysis; ISO:RGD. DR GO; GO:1903076; P:regulation of protein localization to plasma membrane; ISO:RGD. DR GO; GO:0043627; P:response to estrogen; IEP:RGD. DR GO; GO:0009725; P:response to hormone; IDA:RGD. DR GO; GO:0001666; P:response to hypoxia; IEP:RGD. DR GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD. DR GO; GO:1990834; P:response to odorant; IEP:RGD. DR GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD. DR GO; GO:0006979; P:response to oxidative stress; IEP:RGD. DR GO; GO:0001501; P:skeletal system development; IBA:GO_Central. DR GO; GO:0048771; P:tissue remodeling; IDA:RGD. DR GO; GO:0031638; P:zymogen activation; ISO:RGD. DR CDD; cd00094; HX; 1. DR CDD; cd04278; ZnMc_MMP; 1. DR Gene3D; 3.40.390.10; Collagenase (Catalytic Domain); 1. DR Gene3D; 2.110.10.10; Hemopexin-like domain; 1. DR Gene3D; 1.10.101.10; PGBD-like superfamily/PGBD; 1. DR InterPro; IPR000585; Hemopexin-like_dom. DR InterPro; IPR036375; Hemopexin-like_dom_sf. DR InterPro; IPR018487; Hemopexin-like_repeat. DR InterPro; IPR018486; Hemopexin_CS. DR InterPro; IPR033739; M10A_MMP. DR InterPro; IPR024079; MetalloPept_cat_dom_sf. DR InterPro; IPR001818; Pept_M10_metallopeptidase. DR InterPro; IPR021190; Pept_M10A. DR InterPro; IPR021805; Pept_M10A_metallopeptidase_C. DR InterPro; IPR021158; Pept_M10A_Zn_BS. DR InterPro; IPR006026; Peptidase_Metallo. DR InterPro; IPR002477; Peptidoglycan-bd-like. DR InterPro; IPR036365; PGBD-like_sf. DR InterPro; IPR036366; PGBDSf. DR PANTHER; PTHR10201; MATRIX METALLOPROTEINASE; 1. DR PANTHER; PTHR10201:SF24; MATRIX METALLOPROTEINASE-14; 1. DR Pfam; PF11857; DUF3377; 1. DR Pfam; PF00045; Hemopexin; 4. DR Pfam; PF00413; Peptidase_M10; 1. DR Pfam; PF01471; PG_binding_1; 1. DR PIRSF; PIRSF001191; Peptidase_M10A_matrix; 1. DR PRINTS; PR00138; MATRIXIN. DR SMART; SM00120; HX; 4. DR SMART; SM00235; ZnMc; 1. DR SUPFAM; SSF50923; Hemopexin-like domain; 1. DR SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1. DR SUPFAM; SSF47090; PGBD-like; 1. DR PROSITE; PS00546; CYSTEINE_SWITCH; 1. DR PROSITE; PS00024; HEMOPEXIN; 1. DR PROSITE; PS51642; HEMOPEXIN_2; 4. DR PROSITE; PS00142; ZINC_PROTEASE; 1. DR Genevisible; Q10739; RN. PE 2: Evidence at transcript level; KW Calcium; Cleavage on pair of basic residues; Cytoplasm; Disulfide bond; KW Hydrolase; Membrane; Metal-binding; Metalloprotease; Phosphoprotein; KW Protease; Reference proteome; Repeat; Signal; Transmembrane; KW Transmembrane helix; Zinc; Zymogen. FT SIGNAL 1..20 FT /evidence="ECO:0000255" FT PROPEP 21..111 FT /note="Activation peptide" FT /id="PRO_0000028806" FT CHAIN 112..582 FT /note="Matrix metalloproteinase-14" FT /id="PRO_0000028807" FT TOPO_DOM 112..541 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 542..562 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 563..582 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REPEAT 316..364 FT /note="Hemopexin 1" FT REPEAT 365..410 FT /note="Hemopexin 2" FT REPEAT 412..460 FT /note="Hemopexin 3" FT REPEAT 461..508 FT /note="Hemopexin 4" FT REGION 280..317 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 91..98 FT /note="Cysteine switch" FT /evidence="ECO:0000250" FT ACT_SITE 240 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 93 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /note="in inhibited form" FT /evidence="ECO:0000250" FT BINDING 239 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 243 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 249 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10095" FT MOD_RES 399 FT /note="Phosphotyrosine; by PKDCC" FT /evidence="ECO:0000250|UniProtKB:P50281" FT DISULFID 319..508 FT /evidence="ECO:0000250" FT CONFLICT 68 FT /note="M -> I (in Ref. 1; CAA58521)" FT /evidence="ECO:0000305" FT CONFLICT 255 FT /note="A -> D (in Ref. 1; CAA58521)" FT /evidence="ECO:0000305" SQ SEQUENCE 582 AA; 66080 MW; 48F1A8E3065E1AE8 CRC64; MSPAPRPSRS LLLPLLTLGT TLASLGWAQS SNFSPEAWLQ QYGYLPPGDL RTHTQRSPQS LSAAIAAMQR FYGLQVTGKA DSDTMKAMRR PRCGVPDKFG TEIKANVRRK RYAIQGLKWQ HNEITFCIQN YTPKVGEYAT FEAIRKAFRV WESATPLRFR EVPYAYIREG HEKQADIMIL FAEGFHGDST PFDGEGGFLA HAYFPGPNIG GDTHFDSAEP WTVQNEDLNG NDIFLVAVHE LGHALGLEHS NDPSAIMAPF YQWMDTENFV LPDDDRRGIQ QLYGSKSGSP TKMPPQPRTT SRPSVPDKPR NPTYGPNICD GNFDTVAMLR GEMFVFKERW FWRVRNNQVM DGYPMPIGQF WRGLPASINT AYERKDGKFV FFKGDKHWVF DEASLEPGYP KHIKELGRGL PTDKIDAALF WMPNGKTYFF RGNKYYRFNE EFRAVDSEYP KNIKVWEGIP ESPRGSFMGS DEVFTYFYKG NKYWKFNNQK LKVEPGYPKS ALRDWMGCPS GGRPDEGTEE ETEVIIIEVD EEGSGAVSAA AVVLPVLLLL LVLAVGLAVF FFRRHGTPKR LLYCQRSLLD KV //